Academic psychiatry, research ethics, and the drug industryBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3655 (Published 11 June 2013) Cite this as: BMJ 2013;346:f3655
- Derek A Summerfield, honorary senior lecturer1
- 1Institute of Psychiatry, London SE5 8BB, UK
In his article on DSM-5 (the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders), Gornall mentions Charles Nemeroff, a professor at Emory University.1 Nemeroff concealed huge payments made covertly to him by GlaxoSmithKline, makers of the antidepressant paroxetine, while lead investigator on a National Institutes of Health (NIH) study of that very drug.2 Nemeroff was …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial